MedTrace Logo

Mederma to Reduce Appearance of Post Surgical Scars

NCT01504061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-10-24

No results posted yet for this study

Summary

This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N\&I to Mederma Ultra Gel on the appearance of post-surgical scars.

Conditions

  • Scars

Interventions

OTHER

Mederma N&I

Topical gel applied three times a day for eight weeks.

OTHER

Mederma Ultra Gel

Topical gel applied once daily for eight weeks.

Sponsors & Collaborators

  • Merz North America, Inc.

    lead INDUSTRY

Principal Investigators

  • Girish Munavalli, MD, MHS · Dermatology, Laser, and Vein Specialists of Carolinas, PLLC

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-06-30
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01504061 on ClinicalTrials.gov